Skye Bioscience (SKYE) EBITDA (2012 - 2026)
Skye Bioscience's EBITDA was -$10.9 million in Q2 2026, compared with -$18.06 million a year earlier.
Powered by 
Analysis
Skye Bioscience (SKYE) EBITDA (2012 - 2026) Analysis & Trends
On a trailing twelve-month basis, Skye Bioscience's EBITDA was -$51.21 million through Jun 30, 2026; for FY2025, it came in at -$57.44 million.
- In earlier years, EBITDA was -$29.89 million in FY2024, -$34.61 million in FY2023, -$18.2 million in FY2022 and -$7.81 million in FY2021.
- The Q2 2026 figure marks the highest quarterly EBITDA since Q4 2024.
- Per Business Quant data, SKYE's EBITDA in the three quarters before Q2 2026 was -$12.5 million (Q1 2026), -$14.72 million (Q4 2025) and -$13.09 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Skye Bioscience | 7.90 Mn | -80.32 Mn | - | -10.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10.90 Mn |
| Mar 31, 2026 | -12.50 Mn |
| Dec 31, 2025 | -14.72 Mn |
| Sep 30, 2025 | -13.09 Mn |
| Jun 30, 2025 | -18.06 Mn |
| Mar 31, 2025 | -11.58 Mn |
| Dec 31, 2024 | -10.49 Mn |
| Sep 30, 2024 | -4.90 Mn |
| Jun 30, 2024 | -8.37 Mn |
| Mar 31, 2024 | -5.89 Mn |
| Dec 31, 2023 | -3.90 Mn |
| Sep 30, 2023 | -24.67 Mn |
| Jun 30, 2023 | -2.81 Mn |
| Mar 31, 2023 | -3.07 Mn |
| Dec 31, 2022 | -9.24 Mn |
| Sep 30, 2022 | -2.89 Mn |
| Jun 30, 2022 | -3.19 Mn |
| Mar 31, 2022 | -2.71 Mn |
| Dec 31, 2021 | -2.28 Mn |
| Sep 30, 2021 | -1.81 Mn |
API Access
Skye Bioscience EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=SKYE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "SKYE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=SKYE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();